SEI Trust Company’s ANI Pharmaceuticals ANIP Stock Holding History

SEI Trust Company’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-10,180	Closed	-$351K	–	1631
2014 Q2	$351K	Sell	10,180 -3,000	-23%	-$94.1K	﹤0.01%	1196
2014 Q1	$413K	Buy	+13,180	New	+$350K	﹤0.01%	1185

Other funds holding ANIP

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

SEI Trust Company's ANIP Position: Q3 2014 in Review

SEI Trust Company sold out of ANI Pharmaceuticals (ANIP) in Q3 2014, closing a stake of 10,180 shares — an estimated $351K sold.

SEI Trust Company first reported a position in ANIP in Q1 2014 and held it in 2 quarters. The position peaked at $413K in Q1 2014. 72 funds tracked by Wall St. Rank hold ANIP as of Q3 2014.

SEI Trust Company reported no remaining ANI Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
SEI Trust Company sold 10,180 ANI Pharmaceuticals shares in Q3 2014, an estimated $351K.
SEI Trust Company first reported a position in ANI Pharmaceuticals in Q1 2014 and held it in 2 quarters.
SEI Trust Company's ANI Pharmaceuticals position peaked at $413K in Q1 2014.
72 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.